Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells

Veterinary Immunology and Immunopathology

Volumn 131, Issue 3-4, 2009, Pages 218-228

  Wattrang, Eva ^a  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

B cells; Chicken; Oligodeoxyribonucleotides; PBMC; Proliferation

Indexed keywords

CD3 ANTIGEN; IMMUNOGLOBULIN; LIPOFECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEASE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CHICKEN; CONTROLLED STUDY; CYTOPLASM; GENE TARGETING; IN VITRO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL PROLIFERATION; CHICKENS; FEMALE; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHATIDYLETHANOLAMINES; PHOSPHOROTHIOATE OLIGONUCLEOTIDES;

EID: 69949183537     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.04.013     Document Type: Article

References (61)

1. Bartz H., Mendoza Y., Gebker M., Fischborn T., Heeg K., and Dalpke A. Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes. Vaccine 23 (2004) 148-155
2. Bauer S., Kirschning C.J., Häcker H., Redecke V., Hausmann S., Akira S., Wagner H., and Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9237-9242
3. Bauer S., Pigisch S., Hangel D., Kaufmann A., and Hamm S. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9. Immunobiology 213 (2008) 315-328
4. Bennett C.F., Chiang M.Y., Chan H., Shoemaker J.E., and Mirabelli C.K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41 (1992) 1023-1033
5. Bernard M.P., and Phipps R.P. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin. Immunol. 125 (2007) 138-148
6. Bjersing J.L., Eriksson K., Tarkowski A., and Collins L.V. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs. Inflammation 28 (2004) 39-51
7. Boyd A., Philbin V.J., and Smith A.L. Conserved and distinct aspects of the avian Toll-like receptor (TLR) system: implications for transmission and control of bird-borne zoonoses. Biochem. Soc. Trans. 35 (2007) 1504-1507
8. Brown W.C., Estes D.M., Chantler S.E., Kegerreis K.A., and Suarez C.E. DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells. Infect. Immun. 66 (1998) 5423-5432
9. Dalloul R.A., Lillehoj H.S., Okamura M., Xie H., Min W., Ding X., and Heckert R.A. In vivo effects of CpG oligodeoxynucleotide on Eimeria infection in chickens. Avian Dis. 48 (2004) 783-790
10. Domeika K., Magnusson M., Eloranta M.L., Fuxler L., Alm G.V., and Fossum C. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Vet. Immunol. Immunopathol. 101 (2004) 87-102
11. Elias F., Flo J., Lopez R.A., Zorzopulos J., Montaner A., and Rodriguez J.M. Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs. J. Immunol. 171 (2003) 3697-3704
12. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., and Potter A. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect. Immun. 71 (2003) 857-863
13. Gursel I., Gursel M., Ishii K.J., and Klinman D.M. Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J. Immunol. 167 (2001) 3324-3328
14. Hartmann G., Krug A., Bidlingmaier M., Hacker U., Eigler A., Albrecht R., Strasburger C.J., and Endres S. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. J. Pharmacol. Exp. Ther. 285 (1998) 920-928
15. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., Rasmussen W.L., Waldschmidt M., Sajuthi D., Purcell R.H., Davis H.L., and Krieg A.M. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164 (2000) 1617-1624
16. He H., Crippen T.L., Farnell M.B., and Kogut M.H. Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells. Dev. Comp. Immunol. 27 (2003) 621-627
17. He H., Genovese K.J., Lowry V.K., Nisbet D.J., and Kogut M.H. Response of nitric oxide production to CpG oligodeoxynucleotides in turkey and chicken peripheral blood monocytes. FEMS Immunol. Med. Microbiol. 48 (2006) 99-106
18. He H., Genovese K.J., Nisbet D.J., and Kogut M.H. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes. Mol. Immunol. 44 (2007) 3234-3242
19. 2+)] mediate the activation of chicken HD11 macrophage cells by CpG oligodeoxynucleotide. Dev. Comp. Immunol. 32 (2008) 1111-1118
20. He H., and Kogut M.H. CpG-ODN-induced nitric oxide production is mediated through clathrin-dependent endocytosis, endosomal maturation, and activation of PKC, MEK1/2 and p38 MAPK, and NF-kappaB pathways in avian macrophage cells (HD11). Cell Signal. 15 (2003) 911-917
21. He H., Lowry V.K., Ferro P.J., and Kogut M.H. CpG-oligodeoxynucleotide-stimulated chicken heterophil degranulation is serum cofactor and cell surface receptor dependent. Dev. Comp. Immunol. 29 (2005) 255-264
22. Houssaint E., Diez E., and Pink J.R. Ontogeny and tissue distribution of the chicken Bu-1a antigen. Immunology 62 (1987) 463-470
23. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematsu S., Kawai T., Takeuchi O., and Akira S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7 (2006) 40-48
24. Jensen K.E., Neal A.L., Owens R.E., and Warren J. Interferon responses of chick embryo fibroblasts to nucleic acids and related compounds. Nature 200 (1963) 433-434
25. Jiang W., Lederman M.M., Harding C.V., Rodriguez B., Mohner R.J., and Sieg S.F. TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur. J. Immunol. 37 (2007) 2205-2213
26. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4 (2004) 249-258
27. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2879-2883
28. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
29. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5 (2006) 471-484
30. Lanzavecchia A., and Sallusto F. Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr. Opin. Immunol. 19 (2007) 268-274
31. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., and Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98 (1996) 1119-1129
32. Linghua Z., Xingshan T., and Fengzhen Z. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken. Vet. Immunol. Immunopathol. 115 (2007) 216-222
33. Lippmann J., Rothenburg S., Deigendesch N., Eitel J., Meixenberger K., van Laak V., Slevogt H., N'Guessan P.D., Hippenstiel S., Chakraborty T., Flieger A., Suttorp N., and Opitz B. IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell Microbiol. 10 (2008) 2579-2588
34. Magnusson M., Johansson E., Berg M., Eloranta M.L., Fuxler L., and Fossum C. The plasmid pcDNA3 differentially induces production of interferon-alpha and interleukin-6 in cultures of porcine leukocytes. Vet. Immunol. Immunopathol. 78 (2001) 45-56
35. Magnusson M., Magnusson S., Vallin H., Rönnblom L., and Alm G.V. Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotide. Scand. J. Immunol. 54 (2001) 543-550
36. Mena A., Nichani A.K., Popowych Y., Ioannou X.P., Godson D.L., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide. Oligonucleotides 13 (2003) 245-259
37. Patel B.A., Gomis S., Dar A., Willson P.J., Babiuk L.A., Potter A., Mutwiri G., and Tikoo S.K. Oligodeoxynucleotides containing CpG motifs (CpG-ODN) predominantly induce Th1-type immune response in neonatal chicks. Dev. Comp. Immunol. 32 (2008) 1041-1049
38. Peng S.L. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 17 (2005) 230-236
39. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11 (2001) 333-340
40. Roach J.C., Glusman G., Rowen L., Kaur A., Purcell M.K., Smith K.D., Hood L.E., and Aderem A. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9577-9582
41. Roberts T.L., Sweet M.J., Hume D.A., and Stacey K.J. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J. Immunol. 174 (2005) 605-608
42. Rotem Z., Cox R.A., and Isaacs A. Inhibition of virus multiplication by foreign nucleic acid. Nature 197 (1963) 564-566
43. Rothwell C.J., Vervelde L., and Davison T.F. Identification of chicken Bu-1 alloantigens using the monoclonal antibody AV20. Vet. Immunol. Immunopathol. 55 (1996) 225-234
44. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., and Bauer S. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 34 (2004) 2541-2550
45. Schwarz H., Schneider K., Ohnemus A., Lavric M., Kothlow S., Bauer S., Kaspers B., and Staeheli P. Chicken toll-like receptor 3 recognizes its cognate ligand when ectopically expressed in human cells. J. Interferon Cytokine Res. 27 (2007) 97-101
46. Stetson D.B., and Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24 (2006) 93-103
47. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., and Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007) 501-505
48. Takeshita F., Leifer C.A., Gursel I., Ishii K.J., Takeshita S., Gursel M., and Klinman D.M. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167 (2001) 3555-3558
49. Temperley N.D., Berlin S., Paton I.R., Griffin D.K., and Burt D.W. Evolution of the chicken Toll-like receptor gene family: a story of gene gain and gene loss. BMC Genomics 9 (2008) 62
50. Thierry A.R., and Dritschilo A. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res. 20 (1992) 5691-5698
51. Van der Stede Y., Verdonck F., Verfaillie T., Goddeeris B.M., and Cox E. Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes. Vet. Immunol. Immunopathol. 105 (2005) 115-124
52. Verthelyi D., and Zeuner R.A. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 24 (2003) 519-522
53. Vleugels B., Ververken C., and Goddeeris B.M. Stimulatory effect of CpG sequences on humoral response in chickens. Poult. Sci. 81 (2002) 1317-1321
54. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., and Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34 (2004) 251-262
55. Vollmer J., Weeratna R.D., Jurk M., Samulowitz U., McCluskie M.J., Payette P., Davis H.L., Schetter C., and Krieg A.M. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113 (2004) 212-223
56. Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., Tamura T., Takaoka A., Nishikura K., and Taniguchi T. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 5477-5482
57. Wattrang E., Berg M., and Magnusson M. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro. Vet. Immunol. Immunopathol. 107 (2005) 265-279
58. Wernette C.M., Smith B.F., Barksdale Z.L., Hecker R., and Baker H.J. CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation. Vet. Immunol. Immunopathol. 84 (2002) 223-236
59. Xie H., Raybourne R.B., Babu U.S., Lillehoj H.S., and Heckert R.A. CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line. Dev. Comp. Immunol. 27 (2003) 823-834
60. Zhang L., Zhang M., Li J., Cao T., Tian X., and Zhou F. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo. Res. Vet. Sci. 85 (2008) 495-502
61. Zimmermann S., Heeg K., and Dalpke A. Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications. Vaccine 21 (2003) 990-995